INKT – mink therapeutics, inc. (US:NASDAQ)
Stock Stats
News
MiNK Therapeutics (NASDAQ:INKT) was downgraded by analysts at Wall Stree
MiNK Therapeutics and University of Wisconsin–Madison Announce Phase 1 Clinical Trial of Allo-iNKT Cell Therapy (AgenT-797) to Evaluate Prevention of Graft-Versus-Host Disease
MiNK Therapeutics (NASDAQ:INKT) was upgraded by analysts at Wall Street
MiNK Therapeutics (NASDAQ:INKT) was downgraded by analysts at Wall Stree
MiNK Therapeutics (NASDAQ:INKT) was upgraded by analysts at Wall Street
Form 4 MiNK Therapeutics, Inc. For: Jan 02 Filed by: Buell Jennifer
Form 4 MiNK Therapeutics, Inc. For: Jan 02 Filed by: WIINBERG ULF
Form 4 MiNK Therapeutics, Inc. For: Jan 02 Filed by: Ryan Barbara
Form 4 MiNK Therapeutics, Inc. For: Jan 02 Filed by: Corvese Brian
Form 4 MiNK Therapeutics, Inc. For: Jan 02 Filed by: Behner Peter
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.